Search Results - Colm Power

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Neoadjuvant trastuzumab deruxtecan (T-DXd) with response-directed definitive therapy in early stage HER2-positive breast cancer: a phase II study protocol (SHAMROCK study) by Gavin P. Dowling, Sinead Toomey, Philip Bredin, Imelda Parker, Eibhlin Mulroe, Jacinta Marron, Olivia McLoughlin, Ausra Teiserskiene, Colm Power, Anne Marie O’Shea, Megan Greally, Patrick G. Morris, Deirdre Duke, Arnold D. K. Hill, Bryan T. Hennessy

    Published in BMC Cancer (2024-01-01)
    Get full text
    Article


  2. 2

    A bibliometric analysis of HER2-positive breast cancer: 1987–2024 by Sherlissa Ali-Thompson, Gordon R. Daly, Gordon R. Daly, Gavin P. Dowling, Gavin P. Dowling, Conor Kilkenny, Luke Cox, Jason McGrath, Ma’en M. AlRawashdeh, Sindhuja Naidoo, Colm Power, Arnold D. K. Hill, Arnold D. K. Hill

    Published in Frontiers in Oncology (2024-05-01)
    Get full text
    Article


  3. 3

    Prognostic Significance of Delays in Initiation of Adjuvant Trastuzumab-Based Therapy in Patients with HER2-Positive Breast Cancer by Gavin P. Dowling, Aisling Hegarty, Gordon R. Daly, Sandra Hembrecht, Cian M. Hehir, Gavin G. Calpin, Richard Hogan, David O’Reilly, Eithne Downey, Sinead Toomey, Liam Grogan, Oscar Breathnach, Michael Allen, Patrick G. Morris, Colm Power, Leonie S. Young, Arnold D. K. Hill, Bryan T. Hennessy

    Published in Biomedicines (2025-05-01)
    Get full text
    Article


  4. 4

    Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancer by Nicola Cosgrove, Alex J. Eustace, Peter O’Donovan, Stephen F. Madden, Bruce Moran, John Crown, Brian Moulton, Patrick G. Morris, Liam Grogan, Oscar Breathnach, Colm Power, Michael Allen, Janice M. Walshe, Arnold D. Hill, Anna Blümel, Darren O’Connor, Sudipto Das, Małgorzata Milewska, Joanna Fay, Elaine Kay, Sinead Toomey, Bryan T. Hennessy, Simon J. Furney

    Published in npj Breast Cancer (2023-09-01)
    Get full text
    Article


Search Tools: